Butterfly Network, Inc. revenue
Butterfly Network, Inc.'s revenue was $97.6m in fiscal 2025, up 19.0% on the year before. Since fiscal 2019 ($27.6m) it has grown at a compound 23.4% a year. Over the last twelve months it was $123m.
Revenue history
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 46 | 63 | 73 | 66 | 82 | 98 | 123 |
| Growth on the year before | — | +67.7% | +35.3% | +17.3% | −10.2% | +24.5% | +19.0% | — |
| Gross profit | −21 | −61 | 17 | 39 | 17 | 49 | 46 | 87 |
| Gross margin | −75.8% | — | 27.3% | 53.8% | 25.6% | 59.5% | 46.9% | 70.3% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $63.4M | 65.0% | ▲ 17.1% |
| Software and Other Services | $34.2M | 35.0% | ▲ 22.7% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $77.4M | 79.3% | ▲ 22.1% |
| Outside the US | $20.2M | 20.7% | ▲ 8.3% |
From Butterfly Network, Inc.'s 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Butterfly Network, Inc. | $123m | 39.4% | 21.7% |
| Anika Therapeutics, Inc. | $121m | 5.3% | 0.3% |
| Beta Bionics, Inc. | $127m | 43.7% | — |
| Rxsight, Inc. | $128m | -13.2% | 23.9% |
| Outset Medical, Inc. | $118m | -1.3% | -3.1% |
| Owlet, Inc. | $115m | 28.2% | 29.3% |
Compare with peers
- Anika Therapeutics, Inc. revenue
- Beta Bionics, Inc. revenue
- Rxsight, Inc. revenue
- Outset Medical, Inc. revenue
- Owlet, Inc. revenue
Head to head: ANIK vs BFLYBBNX vs BFLYBFLY vs RXST
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies